# TYSABRI (natalizumab) SC Self-Administration
Keywords: TYSABRI, natalizumab, self-administration, subcutaneous, multiple sclerosis, PML, healthcare professionals, cost-savings, flexibility, time-savings

> This page provides information about the self-administration of TYSABRI (natalizumab) via subcutaneous injection, highlighting its benefits, eligibility criteria, and support services for healthcare professionals and patients.

## Details
- [Helping Empower Freedom](#): Overview of TYSABRI SC self-administration and its role in empowering patients.
- [Potential Benefits of Self-Administration](#): Explains how self-administration can improve convenience, reduce costs, enhance flexibility, and save time for both clinics and patients.
- [Self-Administration Eligibility](#): Outlines the criteria for patients eligible for TYSABRI SC self-administration and necessary precautions.
- [TYSABRI SC at Home Service](#): Describes a Biogen-funded homecare service in the UK for eligible patients, offering options for nurse-administered or self-administered care at home.
- [References and Abbreviations](#): Provides a list of references supporting the information and definitions of key abbreviations used on the page.
- [Adverse Event Reporting](#): Details on how to report adverse events in the UK and Ireland, including contact information for Biogen.